Cases 31 - 40 of 115
Amgen Inc. et al v. MSN Laboratories Private Limited et al
as 1:2023cv00031
Plaintiff:
Amgen Inc. and KAI Pharmaceuticals, Inc.
Defendant:
MSN Laboratories Private Limited, MSN Pharmaceuticals Inc. and MSN Life Sciences Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ACADIA Pharmaceuticals Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv01388
Plaintiff:
ACADIA Pharmaceuticals Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Eli Lilly and Company et al v. MSN Laboratories Private Limited et al
as 1:2022cv01115
Plaintiff:
Eli Lilly and Company, Incyte Corporation and Incyte Holdings Corporation
Defendant:
MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. and MSN Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv00945
Plaintiff:
Exelixis, Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. MSN LABORATORIES PRIVATE LIMITED et al
as 2:2022cv01993
Plaintiff:
CELGENE CORPORATION
Defendant:
MSN LABORATORIES PRIVATE LIMITED and MSN PHARMACEUTICALS INC.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Exelixis, Inc. v. MSN Laboratories Private Limited et al
as 1:2022cv00228
Plaintiff:
Exelixis, Inc.
Defendant:
MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In re: Entresto (Sacubitril/Valsartan) Patent Litigation
as 1:2020md02930
Counter Claimant:
Biocon Pharma Limited, Teva Pharmaceuticals USA, Inc., Alkem Laboratories Ltd. and others
Not Classified By Court:
Hetero USA Inc.,, Torrent Pharma Inc., Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Entresto (Sacubitril/Valsartan) Patent Litigation
Counter Defendant:
Novartis Pharmaceuticals Corporation
Defendant:
Noratech Labs, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Acerta Pharma B.V. et al v. MSN Pharmaceuticals Inc.
as 1:2022cv00163
Plaintiff:
Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP and others
Defendant:
MSN Pharmaceuticals Inc. and MSN Laboratories Private Limited
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
